Immunocompromising Conditions CN_HD_ICD10PCS
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.209Copied!
Version20230118Copied!
PublisherB.well Connected Health StewardDate2023-01-18T01:03:05-05:00Descriptionb.well created value set by Sr. Clinical Business Analyst for Flu Vaccine - Adult & Pneumococcal Vaccine - Adult Care Need.
Purpose(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Flu Vaccine - Adult /& Pneumococcal Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Flu Vaccine - Adult & Pneumococcal Vaccine - Adult Need for b.well.),(Inclusion Criteria: Immunocompromising Conditions Codes that constitute the Flu Vaccine - Adult & Pneumococcal Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)
Expansion
Expansion error
Can't resolve code system: http://www.cms.gov/Medicare/Coding/ICD10
systemhttp://www.cms.gov/Medicare/Coding/ICD10
{
"description" : "b.well created value set by Sr. Clinical Business Analyst for Flu Vaccine - Adult & Pneumococcal Vaccine - Adult Care Need.",
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 200
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2023-01-18T01:03:05-05:00",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "B.well Connected Health Steward",
"jurisdiction" : [ {
"coding" : [ {
"system" : "urn:iso:std:iso:3166",
"code" : "US"
} ]
} ],
"purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Flu Vaccine - Adult /& Pneumococcal Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Flu Vaccine - Adult & Pneumococcal Vaccine - Adult Need for b.well.),(Inclusion Criteria: Immunocompromising Conditions Codes that constitute the Flu Vaccine - Adult & Pneumococcal Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)",
"name" : "ImmunocompromisingConditionsCN_HD_ICD10PCS",
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "02YA0Z0",
"display" : "Transplantation of Heart, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "02YA0Z2",
"display" : "Transplantation of Heart, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYC0Z0",
"display" : "Transplantation of Right Upper Lung Lobe, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYC0Z2",
"display" : "Transplantation of Right Upper Lung Lobe, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYD0Z0",
"display" : "Transplantation of Right Middle Lung Lobe, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYD0Z2",
"display" : "Transplantation of Right Middle Lung Lobe, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYF0Z0",
"display" : "Transplantation of Right Lower Lung Lobe, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYF0Z2",
"display" : "Transplantation of Right Lower Lung Lobe, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYG0Z0",
"display" : "Transplantation of Left Upper Lung Lobe, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYG0Z2",
"display" : "Transplantation of Left Upper Lung Lobe, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYH0Z0",
"display" : "Transplantation of Lung Lingula, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYH0Z2",
"display" : "Transplantation of Lung Lingula, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYJ0Z0",
"display" : "Transplantation of Left Lower Lung Lobe, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYJ0Z2",
"display" : "Transplantation of Left Lower Lung Lobe, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYK0Z0",
"display" : "Transplantation of Right Lung, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYK0Z2",
"display" : "Transplantation of Right Lung, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYL0Z0",
"display" : "Transplantation of Left Lung, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYL0Z2",
"display" : "Transplantation of Left Lung, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYM0Z0",
"display" : "Transplantation of Bilateral Lungs, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0BYM0Z2",
"display" : "Transplantation of Bilateral Lungs, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0FSG0ZZ",
"display" : "Reposition Pancreas, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0FSG4ZZ",
"display" : "Reposition Pancreas, Percutaneous Endoscopic Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0FY00Z0",
"display" : "Transplantation of Liver, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0FY00Z2",
"display" : "Transplantation of Liver, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0FYG0Z0",
"display" : "Transplantation of Pancreas, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0FYG0Z2",
"display" : "Transplantation of Pancreas, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0TY00Z0",
"display" : "Transplantation of Right Kidney, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0TY00Z2",
"display" : "Transplantation of Right Kidney, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0TY10Z0",
"display" : "Transplantation of Left Kidney, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0TY10Z2",
"display" : "Transplantation of Left Kidney, Zooplastic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0WY20Z0",
"display" : "Transplantation of Face, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0XYJ0Z0",
"display" : "Transplantation of Right Hand, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "0XYK0Z0",
"display" : "Transplantation of Left Hand, Allogeneic, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233AZ",
"display" : "Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233G0",
"display" : "Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233G2",
"display" : "Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233G3",
"display" : "Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233G4",
"display" : "Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233X0",
"display" : "Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233X2",
"display" : "Transfusion of Allogeneic Related Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233X3",
"display" : "Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233X4",
"display" : "Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233Y0",
"display" : "Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233Y2",
"display" : "Transfusion of Allogeneic Related Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233Y3",
"display" : "Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30233Y4",
"display" : "Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243AZ",
"display" : "Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243G0",
"display" : "Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243G2",
"display" : "Transfusion of Allogeneic Related Bone Marrow into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243G3",
"display" : "Transfusion of Allogeneic Unrelated Bone Marrow into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243G4",
"display" : "Transfusion of Allogeneic Unspecified Bone Marrow into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243X0",
"display" : "Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243X2",
"display" : "Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243X3",
"display" : "Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243X4",
"display" : "Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243Y0",
"display" : "Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243Y2",
"display" : "Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243Y3",
"display" : "Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "30243Y4",
"display" : "Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E00X0M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0130M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0230M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E03005",
"display" : "Introduction of Other Antineoplastic into Peripheral Vein, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0300M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E030U0",
"display" : "Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E030U1",
"display" : "Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E030WL",
"display" : "Introduction of Immunosuppressive into Peripheral Vein, Open",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E03305",
"display" : "Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0330M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E033U0",
"display" : "Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E033U1",
"display" : "Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E033WL",
"display" : "Introduction of Immunosuppressive into Peripheral Vein, Percutaneous",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E04005",
"display" : "Introduction of Other Antineoplastic into Central Vein, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0400M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E040WL",
"display" : "Introduction of Immunosuppressive into Central Vein, Open",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E04305",
"display" : "Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0430M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E043WL",
"display" : "Introduction of Immunosuppressive into Central Vein, Percutaneous",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E05005",
"display" : "Introduction of Other Antineoplastic into Peripheral Artery, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0500M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E050WL",
"display" : "Introduction of Immunosuppressive into Peripheral Artery, Open",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E05305",
"display" : "Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0530M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E053WL",
"display" : "Introduction of Immunosuppressive into Peripheral Artery, Percutaneous",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E06005",
"display" : "Introduction of Other Antineoplastic into Central Artery, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0600M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E060WL",
"display" : "Introduction of Immunosuppressive into Central Artery, Open",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E06305",
"display" : "Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0630M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E063WL",
"display" : "Introduction of Immunosuppressive into Central Artery, Percutaneous",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0930M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0970M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E09X0M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0A30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0B30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0B70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0BX0M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0C30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0C70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0CX0M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0D30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0D70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0DX0M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0E30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0E70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0E80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0F30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0F70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0F80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0G30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0G70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0G80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0H30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0H70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0H80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J3U0",
"display" : "Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J3U1",
"display" : "Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J7U0",
"display" : "Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J7U1",
"display" : "Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J8U0",
"display" : "Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0J8U1",
"display" : "Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0K30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0K70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0K80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0L30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0L70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0M30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0M70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0N30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0N70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0N80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0P30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0P70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0P80M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0Q30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0Q70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0R30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0S30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0U30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0V30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0W30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0Y30M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "3E0Y70M",
"display" : "Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "XW033B3",
"display" : "Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 3",
"version" : "2024"
}, {
"system" : "http://www.cms.gov/Medicare/Coding/ICD10",
"code" : "XW043B3",
"display" : "Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3",
"version" : "2024"
} ],
"total" : 148,
"identifier" : "urn:uuid:586666ad-2dba-459c-a0f2-f049ca932628",
"timestamp" : "2024-04-23T12:26:38-04:00"
},
"title" : "Immunocompromising Conditions CN_HD_ICD10PCS",
"extension" : [ {
"valueString" : "B.well Connected Health Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2023-01-18",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2023-01-18",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "4568760e-8a70-4e8f-b08d-6d2f6519601d",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.209",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1235.209"
} ],
"version" : "20230118"
}